Detalles de la búsqueda
1.
Relative dose intensity of first-line triplet chemotherapy in metastatic colorectal cancer.
Dig Liver Dis
; 2024 Jun 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-38851974
2.
Maintenance Therapy With Cetuximab After FOLFIRI Plus Cetuximab for RAS Wild-Type Metastatic Colorectal Cancer: A Phase 2 Randomized Clinical Trial.
JAMA Netw Open
; 6(9): e2333533, 2023 09 05.
Artículo
en Inglés
| MEDLINE | ID: mdl-37721754
3.
Breast cancer risk by occupation and industry: analysis of the CECILE study, a population-based case-control study in France.
Am J Ind Med
; 54(7): 499-509, 2011 Jul.
Artículo
en Inglés
| MEDLINE | ID: mdl-21472744
4.
Gemcitabine plus nab-paclitaxel until progression or alternating with FOLFIRI.3, as first-line treatment for patients with metastatic pancreatic adenocarcinoma: The Federation Francophone de Cancérologie Digestive-PRODIGE 37 randomised phase II study (FIRGEMAX).
Eur J Cancer
; 136: 25-34, 2020 09.
Artículo
en Inglés
| MEDLINE | ID: mdl-32623182
5.
Rationale and Design of the IROCAS Study: Multicenter, International, Randomized Phase 3 Trial Comparing Adjuvant Modified (m) FOLFIRINOX to mFOLFOX6 in Patients With High-Risk Stage III (pT4 and/or N2) Colon Cancer-A UNICANCER GI-PRODIGE Trial.
Clin Colorectal Cancer
; 18(1): e69-e73, 2019 03.
Artículo
en Inglés
| MEDLINE | ID: mdl-30415988
6.
FOLFOX alone or combined with rilotumumab or panitumumab as first-line treatment for patients with advanced gastroesophageal adenocarcinoma (PRODIGE 17-ACCORD 20-MEGA): a randomised, open-label, three-arm phase II trial.
Eur J Cancer
; 115: 97-106, 2019 07.
Artículo
en Inglés
| MEDLINE | ID: mdl-31129386
7.
Effect of Adding Docetaxel to Androgen-Deprivation Therapy in Patients With High-Risk Prostate Cancer With Rising Prostate-Specific Antigen Levels After Primary Local Therapy: A Randomized Clinical Trial.
JAMA Oncol
; 5(5): 623-632, 2019 May 01.
Artículo
en Inglés
| MEDLINE | ID: mdl-30703190
8.
Low response rate after cetuximab combined with conventional chemoradiotherapy in patients with locally advanced anal cancer: long-term results of the UNICANCER ACCORD 16 phase II trial.
Radiother Oncol
; 114(3): 415-6, 2015 Mar.
Artículo
en Inglés
| MEDLINE | ID: mdl-25769380
Resultados
1 -
8
de 8
1
Próxima >
>>